{"name":"Medimetriks Pharmaceuticals, Inc","slug":"medimetriks-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPd2p4RHowNHR3Y3VRTVJRLXE4VnhTN2hZZFBBUGV4RjFsUXp0UlZXQ3d4V2hyM2xFM1FEeWx2Z1FaTWVBV2k5SjVneGVGbVg3cFowMzlwRklPMDZSS01pTWJiQUE5TkRqcUN5emdzSjdXUnFwZlB1ZG80cllvdGpUMTBYenRWN0EtV1VWUUlnbDV6VVdBTlNWcg?oc=5","date":"2026-02-16","type":"pipeline","source":"Financial Times","summary":"Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with Advancements in Biologics and JAK Inhibitors | DelveInsight – Company Announcement - FT.com - Financial Times","headline":"Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with Advancements in Biologics and JAK Inhibitors | Delve","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE5rb2pqQnlnU0hST1Yxa1ZvSUtURVFHeV9saXdJOTl6THg3enZFUHJ5d29pR0NVR0FRMWp1NU16dS02b1c3cnh2a240R3daZHNsM3o2RUxQQlpqcndoOEFzODBWSkxJRUU?oc=5","date":"2025-08-07","type":"pipeline","source":"Market.us","summary":"Onychomycosis Treatment Market Size, Share | CAGR Of 4.4% - Market.us","headline":"Onychomycosis Treatment Market Size, Share | CAGR Of 4.4%","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-03-18","type":"deal","source":"Valor International","summary":"Eurofarma acquires 60% of Dermage for R$156m - Valor International","headline":"Eurofarma acquires 60% of Dermage for R$156m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTFBwRGNSSUpkekxCN3lvZmRKZkotNzlLeExpMUVNNzJhUEk0Y0xHZ3VGaldaWVAtYTVYTW8ySnVFRDdJajZjay03NkpjRU5BVXJqc0p3UjBtS0EyRHFUOGJSekNjVjZCcV9Iejlha1gzQ3ZWMk5QQXlFeDNR?oc=5","date":"2023-02-03","type":"pipeline","source":"Market.us","summary":"Dermatophytic Onychomycosis Treatment Market CAGR Of 8.46% - Market.us","headline":"Dermatophytic Onychomycosis Treatment Market CAGR Of 8.46%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTE51c1REY0dLNlp3ZEExcGVTSUJjZk9aN1lLR3lwYzJtcFVrd21MN0pucDZ2ZG96Si03YXpkRmRtb0owNVNLNnpkS1B0MDZLUWJBX0t2REhiNVotLTJWdG1TcFFzT0RndTJMaU1Sb2lyZjB2WjQ?oc=5","date":"2022-11-24","type":"pipeline","source":"Straits Research","summary":"Onychomycosis Treatment Market Size, Global Trends, Forecast to 2033 - Straits Research","headline":"Onychomycosis Treatment Market Size, Global Trends, Forecast to 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQWHBlYlR2T0FRMU81dEx2Y0NJdFk0OS1XVEw0MHVMU3FaaEJKXzBFLUc1LTVHdEliZ0dVWFlmblFCUFJnS1NIekdUUklGQThENGdGdFdqMFA3b2kxVWVfVm9TcUNnN0lrM3o2cVZCZFRWSE1PUHRWaXZMVzRjUm1yU2dZd0o4NTFfYkRqV2ZKcVU?oc=5","date":"2022-02-22","type":"pipeline","source":"NJ.com","summary":"Daniel Glassman Obituary (2009) - Newark, NJ - NJ.com","headline":"Daniel Glassman Obituary (2009) - Newark, NJ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNM1dtQW5YSmVnRURQWUJRTVVrN2hONksyWmVoVlNLUzNRRnlVYXlrbVdCVEd3bHRFRUNvMFM4Mlhtb3ZOeW9yRElEeHZDbDlIeGVvVUtMVnRlREx5ZnV5eTU3VktlVFRzQmNqbjJrYWtJcERjenkxeTR2QzVwaFVTWC02bzlKRElKR2c?oc=5","date":"2021-09-17","type":"pipeline","source":"Allied Market Research","summary":"Seborrheic Dermatitis Treatment Market Size, Report by 2031 - Allied Market Research","headline":"Seborrheic Dermatitis Treatment Market Size, Report by 2031","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxOdGFwSWhucGt4Z1BsMS1Yd3M3azctY1FFZUViYU4xdGFQb2lneGY1dHJDUlNFaWhXN1NGQ0dGR1ZlaklIM3ExOEU1dE5aanZvYTNFSDB4Y2FmX3JlcG80cE9JZ1VrNkF3V2xMZmI1cDJvVlp2YjZzcG1XeFZvbVdCNnVJeDVWU2FZSWtDQWtOb0dJLTczaHJHQnVpZVdVNzZDY01hQkFJSWlWUlUwUW8zZkgyLVA4Y0M2SXRJeTZNLVNPeFRiWEVXbWlCZXJPVVBZNWZIa0JuXzlmRmQyb0w4dGs5NC11NzZsRGQw?oc=5","date":"2020-09-18","type":"regulatory","source":"PR Newswire","summary":"Medimetriks' MM36 (difamilast) Atopic Dermatitis Development Program Streamlined Following FDA Meeting - PR Newswire","headline":"Medimetriks' MM36 (difamilast) Atopic Dermatitis Development Program Streamlined Following FDA Meeting","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxONDJfUlAwdUxVSWVoeGlNYzBWemxzcFpWNC1tUHlOOFhwRHVRemQzVWtRSU9pd0ZkZFk4MnhGajMtRkpONWg2UkFBYU1sRkNHWEViN19PT2cweTNURlV3WGJxczFOVmEzVFcxa0o2Y3ZyanRZR180UUg5N2tKRXZ1Q2JSLWlmN25HeGFCTkxuRWFyejBlNlNYZVdDdlFueVpUaDZjVFZYbEZONU1JS1EyUFJxYWZhQVNjeGNWQ0IydjJKZXhlbWFQLWVJajl2dHM?oc=5","date":"2016-02-08","type":"trial","source":"PR Newswire","summary":"Otsuka Licenses Pre-Phase 3 Topical Atopic Dermatitis Treatment to Medimetriks - PR Newswire","headline":"Otsuka Licenses Pre-Phase 3 Topical Atopic Dermatitis Treatment to Medimetriks","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}